• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

tomas.kalincik@unimelb.edu.au

Credentials


Position
Professorial Fellow, Neurological Outcomes
Department of Medicine
Education

Ministry of Health of the Czech Republic
Post Graduate Certificate
University of Melbourne
PhD
University of New South Wales
Bachelors Degree
Charles University in Prague
ORCID

0000-0003-3778-1376

Prof Tomas Kalincik

Professorial Fellow, Neurological Outcomes
Department of Medicine

657 Scholarly works
30 Projects

HIGHLIGHTS

  • 2024

    Research grants (ARC, NHMRC, MRFF)

    New Paradigms in Prevention of Disability in Multiple Sclerosis
  • 2021

    Journal article

    Associations of Disease-Modifying Therapies with COVID-19 Severity in Multiple Sclerosis
    DOI: 10.1212/WNL.0000000000012753
  • 2018

    Research grants (ARC, NHMRC, MRFF)

    Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Central Operating)
  • 2018

    Research Grant

    Arc Training Centre in Cognitive Computing for Medical Technologies (Arc - Stream 1 & 2)
  • 2015

    Journal article

    Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
    DOI: 10.1002/ana.24339
  • 2014

    Journal article

    Fingolimod after natalizumab and the risk of short-term relapse
    DOI: 10.1212/WNL.0000000000000283
  • 2013

    Journal article

    Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
    DOI: 10.1093/brain/awt281
Tomas Kalincik

Latest Honours,
Awards and Fellowships


2021
Dame Kate Campbell Professorial Fellowship MDHS, University of Melbourne
2019
Leonard Cox Award ANZAN
2018
NHMRC Fellowship (NHMRCF)
2017
best poster ECTRIMS-ACTRIMS

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial
    DOI: 10.1016/j.jad.2026.121917
  • 2026

    Journal article

    Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission
    DOI: 10.1016/j.jns.2026.126066
  • 2026

    Journal article

    Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability
    DOI: 10.1212/WNL.0000000000218056
  • 2026

    Journal article

    Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
    DOI: 10.1093/brain/awag047
  • 2026

    Journal article

    Assessing Unmet Social Needs in Multiple Sclerosis Care in Australia: A Qualitative Assessment of Feasibility, Barriers and Enablers
    DOI: 10.1111/hex.70691
  • 2026

    Journal article

    Plasma proteome in LGI-1 autoimmune encephalitis.
    DOI: 10.1186/s12974-026-03851-x
  • 2026

    Journal article

    The relationship between cognitive complaints and burden of non-cognitive symptoms in multiple sclerosis
    DOI: 10.1192/bjo.2026.11041
  • 2026

    Journal article

    Acute and longitudinal magnetic resonance imaging abnormalities in antibody-mediated encephalitis
    DOI: 10.1093/braincomms/fcag193

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224